FDA pulls up Aurobindo Pharma for 'repeated' failures in CGMP
Posted by
www.biotecnika.org
The FDA recently issued a letter warning the drug- makers unit X1 in
Srikakulam district of Andhra Pradesh for deviations from CGMP for
API.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/fda-pulls-up-aurobindo-pharma-for-repeated-failures-in-cgmp/articleshow/70059427.cms
Subscribe to:
Post Comments (Atom)
Post a Comment